Register for email alerts and news feeds:
This journal | BMJ Group
rss
Evidence-Based Medicine 2007;12:13; doi:10.1136/ebm.12.1.13
Copyright © 2007 by the BMJ Publishing Group Ltd.

Therapeutics

Review: anticholinergics but not ß2 agonists reduce exacerbations requiring hospital admission and respiratory deaths in COPD

Salpeter SR, Buckley NS, Salpeter EE. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med 2006;21:1011–9.[CrossRef][Medline]

Q How effective are anticholinergics and ß2 agonists for chronic obstructive pulmonary disease (COPD)?

Clinical impact ratings GP/FP/Primary care ******{star} IM/Ambulatory care ******{star} Respirology ******{star}

Key Words: adrenergic beta-agonists • albuterol • bronchodilator agents • ethanolamines • lung diseases (obstructive)

The first 150 words of the full text of this article appear below.

METHODS

Formula Data sources: Medline, EMBASE/Excerpta Medica, and Cochrane databases (to December 2005); US Food and Drug Administration website; and references of identified reviews.

Formula Study selection and assessment: randomised controlled trials (RCTs) in any language that compared anticholinergics or ß2 agonists with placebo or with each other; had >=3 month follow up; and reported COPD exacerbations requiring study withdrawal or hospital admission, or respiratory death. 22 RCTs (n = 15 276, mean age range 60–64 y) with mean 20 month follow up (range 3–60 mo) met the selection criteria. Methodological quality of individual studies was based on randomisation procedure and allocation concealment, blinding of patients and providers, reporting of withdrawals and dropouts, and intention to treat analysis.

Formula Outcomes: exacerbations causing withdrawal from the study, severe exacerbations requiring hospital admission, and respiratory death.

MAIN RESULTS

Anticholinergics used were ipratropium and tiotropium. ß2 agonists used were albuterol, metaproterenol, formoterol, and salmeterol. Compared with placebo, anticholinergics reduced . . . [Full text of this article]

Shirin Shafazand, MD, MS, FRCPC

University of Miami, Miller School of Medicine,
Miami, Florida, USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.